Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across multiple therapeutic areas-Reference-Cited by-同舟云学术

Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across multiple therapeutic areas

Published:2022-04-08 Issue:6 Volume:38 Page:981-991
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Alderfer Justine¹^ORCID,Alvir Jose M. J.²,Cook Joseph P.³,Gilchrist Kim⁴,Maculaitis Martine C.⁵,Thompson Jeffrey⁵

Affiliation:

1. Medical Affairs, Pfizer Inc, Collegeville, PA, USA

2. Statistical Research and Data Science Center, Global Biometrics and Data Management, Global Product Development, Pfizer Inc, New York, NY, USA

3. Medical Analytics and Real World Evidence, Viatris, Canonsburg, PA, USA

4. North American Medical Affairs, Viatris, Canonsburg, PA, USA

5. RWE Data and Analytics, Cerner Enviza, Malvern, PA, USA

Funder

Upjohn, formerly a division of Pfizer, and now part of Viatris

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2050109

Reference39 articles.

1. US Food and Drug Administration. Generic drugs [Internet]. 2021

2. [cited 2021 Feb 10]. Available from: https://www.fda.gov/drugs/buying-using-medicine-safely/generic-drugs.

3. US Food and Drug Administration. FDA list of authorized generic drugs [Internet]; 2021. [cited 2021 May 15]. Available from: https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/fda-list-authorized-generic-drugs.

4. A 2013 Survey of Clinical Practice Patterns in the Management of Primary Hypothyroidism

5. When thyroid hormone replacement is ineffective?